Literature DB >> 20436036

Cardiac resynchronization therapy for the causal treatment of heart failure with preserved ejection fraction: insight from a pressure-volume loop analysis.

Martin Penicka1, Viktor Kocka, Dalibor Herman, Helena Trakalova, Martin Herold.   

Abstract

This case describes a middle-aged patient with normal ejection fraction (64%) and significant dyspnoea which could not be explained by results from routine examinations. A pressure-volume loop analysis revealed severe left ventricular (LV) dyssynchrony to be the underlying mechanism of heart failure. The patient underwent implantation of a biventricular pacemaker. Cardiac resynchronization therapy (CRT) was associated with an immediate reduction in LV dyssynchrony from 32 to 13%, decrease in LV end-diastolic pressure from 19 to 8 mmHg, and increased exercise tolerance during follow-up. Thus, CRT may be considered a causal therapy in selected patients with heart failure and preserved ejection fraction.

Entities:  

Mesh:

Year:  2010        PMID: 20436036     DOI: 10.1093/eurjhf/hfq068

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  9 in total

Review 1.  Novel paradigms in the therapeutic management of heart failure with preserved ejection fraction: clinical perspectives.

Authors:  Fayez El Shear
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

Review 2.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Bharathi Upadhya; George E Taffet; Che Ping Cheng; Dalane W Kitzman
Journal:  J Mol Cell Cardiol       Date:  2015-03-06       Impact factor: 5.000

Review 3.  Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions.

Authors:  Bharathi Upadhya; Mark J Haykowsky; Dalane W Kitzman
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

4.  The mechanical and hemodynamic effects of left ventricular pacing in heart failure with preserved ejection fraction and left bundle branch block.

Authors:  Daniel J Friedman; Kasper Emerek; Peter Søgaard; Maryam Vejdani-Jahromi; Joseph Kisslo; Brett D Atwater
Journal:  J Electrocardiol       Date:  2018-07-10       Impact factor: 1.438

Review 5.  Therapeutic Approaches in Heart Failure with Preserved Ejection Fraction (HFpEF) in Children: Present and Future.

Authors:  Bibhuti B Das
Journal:  Paediatr Drugs       Date:  2022-05-02       Impact factor: 3.022

Review 6.  Atrioventricular and interventricular delay optimization in cardiac resynchronization therapy: physiological principles and overview of available methods.

Authors:  Patrick Houthuizen; Frank A L E Bracke; Berry M van Gelder
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

Review 7.  Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?

Authors:  Jia Li; Peter Moritz Becher; Stefan Blankenberg; Dirk Westermann
Journal:  Cardiol Res Pract       Date:  2013-10-24       Impact factor: 1.866

Review 8.  Heart Failure with Preserved Ejection Fraction: Can Device Therapy Be Our Option?

Authors:  Talha Ahmed
Journal:  Cureus       Date:  2020-03-19

9.  Left bundle-branch block is associated with asimilar dyssynchronous phenotype in heart failure patients with normal and reduced ejection fractions.

Authors:  Daniel J Friedman; Kasper Emerek; Joseph Kisslo; Peter Søgaard; Brett D Atwater
Journal:  Am Heart J       Date:  2020-10-22       Impact factor: 4.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.